Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach Christian McNeely, MD, Alan Zajarias, MD, Randall Robbs, MBA, Stephen Markwell, MA, Christina M. Vassileva, MD The Annals of Thoracic Surgery Volume 103, Issue 6, Pages 1808-1814 (June 2017) DOI: 10.1016/j.athoracsur.2017.02.056 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Adjusted effect of age 90 years or older (age ≥90 yrs) and TA (transapical) access among patients 90 years or older on outcomes. (CI = confidence interval; D = day; HR = hazard ratio.) The Annals of Thoracic Surgery 2017 103, 1808-1814DOI: (10.1016/j.athoracsur.2017.02.056) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Long-term survival after transcatheter aortic valve replacement (TAVR) stratified by age group. The p value is in reference to transfemoral versus transapical TAVR. Unable to calculate the p values compared with expected because expected population are observed values. Hashed lines represent 95% confidence intervals. (post-op = post-operative.) The Annals of Thoracic Surgery 2017 103, 1808-1814DOI: (10.1016/j.athoracsur.2017.02.056) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Long-term survival after transcatheter aortic valve replacement (TAVR) among patients 90 years or older, stratified by access site. The p value is in reference to transfemoral versus transapical TAVR. Unable to calculate p values compared with expected because expected population are observed values. Hashed lines represent 95% confidence intervals. (post-op = post-operative.) The Annals of Thoracic Surgery 2017 103, 1808-1814DOI: (10.1016/j.athoracsur.2017.02.056) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions